Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
Welcome to Pump.fun!
Pump lets anyone create coins, giving everyone equal access to buy and sell from the start. Prices can move quickly, so trade carefully.
By clicking this button, you agree to the Terms and Conditions, Privacy Policy, and certify that you are over 18 years old.
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
 Biggie_ | $150.52% |
 rzzzz | $20.06% |
 RrFeF | $0.760.03% |
 Clooden | $0.000.00% |
 AAiyaa | $0.000.00% |
 mainwhale71209 | $0.000.00% |
 vilesalmon30147 | $0.000.00% |
 Jargoon | $0.000.00% |
 jonii | $0.000.00% |
 AvatarAan | $0.000.00% |
 infiniteXXX | $0.000.00% |
 elliass | $0.000.00% |
| $0.000.00% |
In a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses data from individual cells inside tumors to predict whether a person’s cancer will respond to a specific drug. Researchers at the National Cancer Institute (NCI), part of NIH, published their work on April 18, 2024, in Nature Cancer, and suggest that such single-cell RNA sequencing data could one day be used to help doctors more precisely match cancer patients with drugs that will be effective for their cancer.